Lupus Coagulation Inhibitor
"Lupus Coagulation Inhibitor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiphospholipid antibody found in association with systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC;), ANTIPHOSPHOLIPID SYNDROME; and in a variety of other diseases as well as in healthy individuals. In vitro, the antibody interferes with the conversion of prothrombin to thrombin and prolongs the partial thromboplastin time. In vivo, it exerts a procoagulant effect resulting in thrombosis mainly in the larger veins and arteries. It further causes obstetrical complications, including fetal death and spontaneous abortion, as well as a variety of hematologic and neurologic complications.
| Descriptor ID |
D016682
|
| MeSH Number(s) |
D12.776.124.486.485.114.323.210.600 D12.776.124.790.651.114.323.210.600 D12.776.377.715.548.114.323.210.600 D23.113.475
|
| Concept/Terms |
Lupus Coagulation Inhibitor- Lupus Coagulation Inhibitor
- Inhibitor, Lupus Coagulation
- Coagulation Inhibitor, Lupus
- Lupus Anticoagulant
- Anticoagulant, Lupus
|
Below are MeSH descriptors whose meaning is more general than "Lupus Coagulation Inhibitor".
Below are MeSH descriptors whose meaning is more specific than "Lupus Coagulation Inhibitor".
This graph shows the total number of publications written about "Lupus Coagulation Inhibitor" by people in this website by year, and whether "Lupus Coagulation Inhibitor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 1 | 2 |
| 2002 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lupus Coagulation Inhibitor" by people in Profiles.
-
Effendi MUN, Majid H, Moiz B, Jafri L, Zehra N, Khan AH. Unveiling the clinical spectrum: Exploring the role of anti-?2glycoprotein-1 antibodies (anti-?2GPI) in antiphospholipid syndrome suspects. Int J Immunopathol Pharmacol. 2025 Jan-Dec; 39:3946320251316724.
-
Jennings I, Kitchen S, Kitchen DP, Woods TA, Walker ID. ISTH/SSC lupus anticoagulant testing guidelines: how far have these been adopted by laboratories? J Thromb Haemost. 2011 Oct; 9(10):2117-9.
-
Di Gennaro L, Maggi F, Novarese L, Cipriani MC, Bonomo L, Landolfi R. Bilateral axillary vein thrombosis in a young patient with lupus anticoagulant and clavicular bone spurs. Thromb Haemost. 2007 Dec; 98(6):1374-6.
-
Jennings I, Greaves M, Mackie IJ, Kitchen S, Woods TA, Preston FE. Lupus anticoagulant testing: improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. Br J Haematol. 2002 Nov; 119(2):364-9.
-
Castillo IG, Foroozan R, Sergott RC. A sticky situation. Surv Ophthalmol. 2002 Sep-Oct; 47(5):491-9.
-
Arkel YS, Ku D, Kamiyama M, Pajaro R, Alder H, Marchand A. A highly specific functional test for factor V leiden: A modified tissue factor assay for activated protein C resistance. Haemostasis. 1997 Nov-Dec; 27(6):290-304.
-
Jennings I, Kitchen S, Woods TA, Preston FE, Greaves M. Potentially clinically important inaccuracies in testing for the lupus anticoagulant: an analysis of results from three surveys of the UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Thromb Haemost. 1997 May; 77(5):934-7.
-
Rauch J, Janoff AS. Antibodies against phospholipids other than cardiolipin: potential roles for both phospholipid and protein. Lupus. 1996 Oct; 5(5):498-502.
-
Rauch J, Janoff AS. Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo. Proc Natl Acad Sci U S A. 1990 Jun; 87(11):4112-4.
-
Rauch J, Tannenbaum M, Janoff AS. Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost. 1989 Nov 24; 62(3):892-6.